These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24550329)

  • 21. The quest of the best - A SAR study of trithiolato-bridged dinuclear Ruthenium(II)-Arene compounds presenting antiparasitic properties.
    Păunescu E; Boubaker G; Desiatkina O; Anghel N; Amdouni Y; Hemphill A; Furrer J
    Eur J Med Chem; 2021 Oct; 222():113610. PubMed ID: 34144354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.
    Spalenka J; Escotte-Binet S; Bakiri A; Hubert J; Renault JH; Velard F; Duchateau S; Aubert D; Huguenin A; Villena I
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133550
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeted Phenotypic Screening in
    Subramanian G; Belekar MA; Shukla A; Tong JX; Sinha A; Chu TTT; Kulkarni AS; Preiser PR; Reddy DS; Tan KSW; Shanmugam D; Chandramohanadas R
    mSphere; 2018; 3(1):. PubMed ID: 29359192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Host Cell Metabolism Contributes to Delayed-Death Kinetics of Apicoplast Inhibitors in Toxoplasma gondii.
    Amberg-Johnson K; Yeh E
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455243
    [No Abstract]   [Full Text] [Related]  

  • 25. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro.
    Strobl JS; Cassell M; Mitchell SM; Reilly CM; Lindsay DS
    J Parasitol; 2007 Jun; 93(3):694-700. PubMed ID: 17626366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of potent phosphodiesterase inhibitors that demonstrate cyclic nucleotide-dependent functions in apicomplexan parasites.
    Howard BL; Harvey KL; Stewart RJ; Azevedo MF; Crabb BS; Jennings IG; Sanders PR; Manallack DT; Thompson PE; Tonkin CJ; Gilson PR
    ACS Chem Biol; 2015 Apr; 10(4):1145-54. PubMed ID: 25555060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway.
    Fomovska A; Huang Q; El Bissati K; Mui EJ; Witola WH; Cheng G; Zhou Y; Sommerville C; Roberts CW; Bettis S; Prigge ST; Afanador GA; Hickman MR; Lee PJ; Leed SE; Auschwitz JM; Pieroni M; Stec J; Muench SP; Rice DW; Kozikowski AP; McLeod R
    Antimicrob Agents Chemother; 2012 May; 56(5):2666-82. PubMed ID: 22354304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of potential dual -targets anti- toxoplasma gondii compounds through structure-based virtual screening and in-vitro studies.
    Salin NH; Noordin R; Al-Najjar BO; Kamarulzaman EE; Yunus MH; Karim IZA; Nasim NNM; Zakaria II; Wahab HA
    PLoS One; 2020; 15(5):e0225232. PubMed ID: 32442170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bis(oxyphenylene)benzimidazoles: a novel class of anti-Plasmodium falciparum agents.
    Mayence A; Vanden Eynde JJ; Kaiser M; Brun R; Yarlett N; Huang TL
    Bioorg Med Chem; 2011 Dec; 19(24):7493-500. PubMed ID: 22061825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Original quinazoline derivatives displaying antiplasmodial properties.
    Kabri Y; Azas N; Dumètre A; Hutter S; Laget M; Verhaeghe P; Gellis A; Vanelle P
    Eur J Med Chem; 2010 Feb; 45(2):616-22. PubMed ID: 19926173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One-pot, multicomponent synthesis of 2,3-disubstituted quinazolin-ones with potent and selective activity against Toxoplasma gondii.
    Brown CE; Kong T; Bordón C; Yolken R; Jones-Brando L; McNulty J
    Bioorg Med Chem Lett; 2018 May; 28(9):1642-1646. PubMed ID: 29598911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I.
    McLeod R; Muench SP; Rafferty JB; Kyle DE; Mui EJ; Kirisits MJ; Mack DG; Roberts CW; Samuel BU; Lyons RE; Dorris M; Milhous WK; Rice DW
    Int J Parasitol; 2001 Feb; 31(2):109-13. PubMed ID: 11239932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway.
    Fletcher S; Lucantoni L; Sykes ML; Jones AJ; Holleran JP; Saliba KJ; Avery VM
    Parasit Vectors; 2016 Nov; 9(1):589. PubMed ID: 27855724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repurposing the open access malaria box to discover potent inhibitors of Toxoplasma gondii and Entamoeba histolytica.
    Boyom FF; Fokou PV; Tchokouaha LR; Spangenberg T; Mfopa AN; Kouipou RM; Mbouna CJ; Donfack VF; Zollo PH
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5848-54. PubMed ID: 25049259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxylamine and Carboxymethoxylamine Can Inhibit
    Li J; Guo H; Galon EM; Gao Y; Lee SH; Liu M; Li Y; Ji S; Jia H; Xuan X
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907178
    [No Abstract]   [Full Text] [Related]  

  • 36. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
    Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
    Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.
    Mui EJ; Jacobus D; Milhous WK; Schiehser G; Hsu H; Roberts CW; Kirisits MJ; McLeod R
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3463-7. PubMed ID: 16048961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salicylanilide inhibitors of Toxoplasma gondii.
    Fomovska A; Wood RD; Mui E; Dubey JP; Ferreira LR; Hickman MR; Lee PJ; Leed SE; Auschwitz JM; Welsh WJ; Sommerville C; Woods S; Roberts C; McLeod R
    J Med Chem; 2012 Oct; 55(19):8375-91. PubMed ID: 22970937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of bromodomain protein inhibitors/binders against asexual-stage Plasmodium falciparum parasites.
    Chua MJ; Robaa D; Skinner-Adams TS; Sippl W; Andrews KT
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):189-193. PubMed ID: 29631126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and Synthesis of Terephthalic Acid-Based Histone Deacetylase Inhibitors with Dual-Stage Anti-Plasmodium Activity.
    Stenzel K; Chua MJ; Duffy S; Antonova-Koch Y; Meister S; Hamacher A; Kassack MU; Winzeler E; Avery VM; Kurz T; Andrews KT; Hansen FK
    ChemMedChem; 2017 Oct; 12(19):1627-1636. PubMed ID: 28812327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.